Estee Lauder Companies, Inc. (T
97.36-1.40 (-1.42%)
Oct 29, 4:00:02 PM EDT · NYSE · EL · USD
Key Stats
Market Cap
35.08BP/E (TTM)
-Basic EPS (TTM)
-3.15Dividend Yield
0.02%Recent Filings
8-K
Geographic reporting reorg
The Estée Lauder Companies reorganized its geographic reporting structure effective July 1, 2025, splitting into four regions: The Americas, EUKEM, Asia/Pacific, and Mainland China, while excluding intercompany royalties, allocating corporate expenses globally, and distributing manufacturing impacts. This streamlines operations amid leadership shifts but leaves consolidated results unchanged. Recast fiscal 2025 data shows organic net sales down 8% to $14,323 million, with adjusted operating income falling 28% to $1,146 million. Investors gain clearer regional insights, yet Asia/Pacific sales plunged 21%.
8-K
Updated stock option terms
The Estée Lauder Companies updated its stock option award agreement on August 21, 2025, for executive officers and employees under the Amended and Restated Fiscal 2002 Share Incentive Plan. Non-retirement-eligible staff now get pro rata vesting on involuntary termination without cause, while retirement-eligible ones retain full vesting. Expanded restrictive covenants—non-compete, non-solicit, non-disparagement—apply, with forfeiture and clawback for breaches. This tightens retention amid talent wars.
10-K
FY2025 results
The Estée Lauder Companies posted FY2025 net sales of $14.3B, down 8% y/y, with Q4 reflecting persistent weakness in Asia travel retail and mainland China amid subdued consumer sentiment, though sequential improvements emerged in North America via Amazon launches. Skin care fell 12% annually, driven by Estée Lauder and La Mer declines, yet Q4 showed modest q/q stabilization in hero franchises; makeup dipped 6% but accelerated in Q4 on Clinique's e-commerce gains, while fragrance held flat with Le Labo offsetting TOM FORD softness. Gross margins expanded 230bps to 74.0% on supply chain efficiencies, but operating loss widened to $(785)M from $970M profit, hit by $1.3B in impairments on TOM FORD, Dr.Jart+, and Too Faced. Cash from operations dropped to $1.3B, supporting $1.1B dividends; no buybacks resumed. Q4 momentum hints at recovery, but tariffs loom large.
8-K
EL reports FY25 sales decline
The Estée Lauder Companies reported fiscal 2025 net sales of $14.3 billion, down 8% from prior year, with adjusted operating margin slipping to 8.0% amid $1.3 billion in asset impairments and $362 million restructuring charges. Yet gross margin expanded 230 basis points to 74.0% via Profit Recovery and Growth Plan efficiencies. New leadership eyes organic sales growth of 0-3% in fiscal 2026, targeting adjusted EPS of $1.87-$2.07 despite $100 million tariff headwinds. Momentum builds in key markets.
8-K
Board members to depart
The Estée Lauder Companies announced on July 9, 2025, that board members Lynn Forester de Rothschild and Angela Wei Dong will depart at the 2025 Annual Meeting. De Rothschild, a Class II director since 2000 and Nominating and ESG Committee member, won't seek re-election; Dong, a Class III director since 2022 and Audit Committee member, will retire the day prior. No disagreements prompted their exits. Board refreshment proceeds smoothly.
IPO
Website
Employees
Sector
Industry
CL
Colgate-Palmolive Company
75.73-1.41
COTY
Coty Inc.
3.95-0.07
ELF
e.l.f. Beauty, Inc.
126.99-4.71
HNST
The Honest Company, Inc.
3.46-0.14
NUS
Nu Skin Enterprises, Inc.
10.65-0.09
PG
Procter & Gamble Company (The)
148.77-2.60
PUGBY
PUIG BRANDS S A
7.70-0.29
SKIN
The Beauty Health Company
1.45-0.01
SKVI
SKINVISIBLE INC
0.50+0.00
UL
Unilever PLC
60.97-0.95